Afficher la notice abrégée

Diabetic Nephropathy

dc.contributor.editorChan, John S. D.
dc.date.accessioned2021-04-20T15:31:42Z
dc.date.available2021-04-20T15:31:42Z
dc.date.issued2012
dc.identifierONIX_20210420_9789535105435_1376
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/66018
dc.description.abstractInternationally renowned experts have provided data on their own studies, and discuss the relative usefulness of their work in relation to diabetic nephropathy. The first section describes the novel role of intrarenal renin-angiotensin-aldosterone system (RAAS) and oxidative stress in the development of diabetic nephropathy and discusses the current and novel pharmacological interventions in the treatment of diabetic nephropathy. The second section discusses other important contributors outside of the RAAS in the pathogenesis of diabetic nephropathy including AGE/RAGE, epithelial-mesenchymal-transition (EMT) and immune cytokines. Features: Provides novel information on various pathophysiological determinants in the development of diabetic nephropathy Provides novel information on various pharmacological interventions of diabetic nephropathy
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJQ Ophthalmologyen_US
dc.subject.otherRenal medicine & nephrology
dc.titleDiabetic Nephropathy
dc.typebook
oapen.identifier.doi10.5772/1889
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789535105435
oapen.relation.isbn9789535169789
oapen.imprintIntechOpen
oapen.pages178


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/